Veru Inc (VERU)

Veru Inc (VERU) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $41.9M; returns 1 day -2.2%, 1 week -2.6%, 1 year -39.8%.

Veru Inc. is a late-stage biopharmaceutical company focused on developing innovative medicines for cardiometabolic and inflammatory diseases. Following the divestiture of its FC2 Female Condom business in December 2024 for $18 million, Veru has strategically pivoted to focus on drug development, particularly in the obesity and cardiovascular disease sectors.

Groups VERU belongs to

• Biopharmaceutical
• Clinical Stage Biopharma
• Strategic Pivot
• Metabolic Disorders
• Weight Management
• GLP-1 Agonists
• Biotechnology
• Cardiovascular Therapies
• Healthcare
• Pharmaceuticals
• Clinical Stage

VERU financial model: income statement, cash flow and balance sheet